DK1188830T3 - Nyt hæmopoietinreceptorprotein NR10 - Google Patents

Nyt hæmopoietinreceptorprotein NR10

Info

Publication number
DK1188830T3
DK1188830T3 DK00931646.4T DK00931646T DK1188830T3 DK 1188830 T3 DK1188830 T3 DK 1188830T3 DK 00931646 T DK00931646 T DK 00931646T DK 1188830 T3 DK1188830 T3 DK 1188830T3
Authority
DK
Denmark
Prior art keywords
novel
hemopoietin
receptors
hematopoietic
immune system
Prior art date
Application number
DK00931646.4T
Other languages
English (en)
Inventor
M Maeda
N Yaguchi
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26483716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1188830(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK1188830T3 publication Critical patent/DK1188830T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00931646.4T 1999-06-02 2000-06-01 Nyt hæmopoietinreceptorprotein NR10 DK1188830T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15579799 1999-06-02
JP21779799 1999-07-30
PCT/JP2000/003556 WO2000075314A1 (fr) 1999-06-02 2000-06-01 Proteine receptrice d'hemopoietine

Publications (1)

Publication Number Publication Date
DK1188830T3 true DK1188830T3 (da) 2010-04-26

Family

ID=26483716

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00931646.4T DK1188830T3 (da) 1999-06-02 2000-06-01 Nyt hæmopoietinreceptorprotein NR10

Country Status (11)

Country Link
US (6) US7482440B2 (da)
EP (3) EP1188830B1 (da)
JP (7) JP2007111051A (da)
AT (1) ATE455852T1 (da)
AU (1) AU4952400A (da)
CY (1) CY1115582T1 (da)
DE (1) DE60043728D1 (da)
DK (1) DK1188830T3 (da)
ES (1) ES2339843T3 (da)
PT (1) PT1188830E (da)
WO (1) WO2000075314A1 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1188830B1 (en) * 1999-06-02 2010-01-20 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein ,nr10
AU7445900A (en) * 1999-09-27 2001-04-30 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, nr12
US20030096339A1 (en) 2000-06-26 2003-05-22 Sprecher Cindy A. Cytokine receptor zcytor17
PT1325115T (pt) * 2000-06-26 2016-09-28 Zymogenetics Inc Recetor de citocina zcytor17
US7317075B2 (en) * 2000-07-20 2008-01-08 Genentech, Inc. PRO21384 polypeptides
CA2425169A1 (en) * 2000-10-06 2002-04-11 Immunex Corporation Hematopoietin receptors hpr1 and hpr2
WO2002077230A1 (fr) * 2001-03-26 2002-10-03 Chugai Seiyaku Kabushiki Kaisha Variants d'epissage nr10
US9738700B2 (en) 2002-01-18 2017-08-22 Zymogenetics Inc. ZCYTOR17 heterodimeric cytokine receptor
PT1576112E (pt) * 2002-01-18 2012-05-25 Zymogenetics Inc Multímeros de receptor de citocina zcytor17
CN100575482C (zh) 2002-01-18 2009-12-30 津莫吉尼蒂克斯公司 新的细胞因子zcytor17配体
AU2003215548A1 (en) * 2002-02-01 2003-09-02 Bayer Healthcare Ag Regulation of human hematopoietin receptor-like protein
ATE431406T1 (de) * 2002-02-25 2009-05-15 Genentech Inc Neuer typ-1-cytokinrezeptor glm-r
US20060182743A1 (en) 2005-02-14 2006-08-17 Janine Bilsborough Methods of treating skin disorders using an IL-31RA antagonist
CN101198624B (zh) 2005-05-06 2012-10-10 津莫吉尼蒂克斯公司 Il-31单克隆抗体及使用方法
US20130216542A1 (en) 2005-05-06 2013-08-22 Zymogenetics, Inc. Variable region sequences of il-31 monoclonal antibodies and methods of use
US8101183B2 (en) 2005-05-06 2012-01-24 Zymogentics, Inc. Variable region sequences of IL-31 monoclonal antibodies
AU2007249713A1 (en) 2006-01-10 2007-11-22 Zymogenetics, Inc. Methods of treating pain and inflammation in neuronal tissue using IL-31Ra and OSMRb antagonists
US11046784B2 (en) 2006-03-31 2021-06-29 Chugai Seiyaku Kabushiki Kaisha Methods for controlling blood pharmacokinetics of antibodies
DK2047863T3 (da) 2006-06-08 2013-09-16 Chugai Pharmaceutical Co Ltd Middel til forebyggelse eller behandling af inflammatoriske sygdomme
MX369784B (es) 2007-09-26 2019-11-21 Chugai Pharmaceutical Co Ltd Metodo de modificacion del punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en region de determinacion de complementariedad (cdr).
PH12018501459A1 (en) 2007-09-26 2019-11-11 Chugai Pharmaceutical Co Ltd Modified antibody constant region
EP2236604B1 (en) 2007-12-05 2016-07-06 Chugai Seiyaku Kabushiki Kaisha Anti-nr10 antibody and use thereof
EP2241332A4 (en) 2007-12-05 2011-01-26 Chugai Pharmaceutical Co Ltd THERAPEUTIC AGENT AGAINST PRITURE
HUE036548T2 (hu) 2007-12-07 2018-08-28 Zymogenetics Inc IL-31-re specifikus humanizált antitest molekulák
DK2708559T3 (da) 2008-04-11 2018-06-14 Chugai Pharmaceutical Co Ltd Antigenbindende molekyle, som er i stand til gentagne at binde to eller flere antigenmolekyler
WO2010048543A2 (en) * 2008-10-23 2010-04-29 Alta Devices, Inc. Thin absorber layer of a photovoltaic device
KR20160062207A (ko) * 2008-12-05 2016-06-01 추가이 세이야쿠 가부시키가이샤 항ｎｒ１０ 항체 및 그의 이용
JP5139517B2 (ja) * 2008-12-05 2013-02-06 中外製薬株式会社 抗ｎｒ１０抗体、およびその利用
JP2010210772A (ja) 2009-03-13 2010-09-24 Dainippon Screen Mfg Co Ltd 液晶表示装置の製造方法
JP5787446B2 (ja) 2009-03-19 2015-09-30 中外製薬株式会社 抗体定常領域改変体
JP5717624B2 (ja) 2009-03-19 2015-05-13 中外製薬株式会社 抗体定常領域改変体
CN108715614A (zh) 2010-11-30 2018-10-30 中外制药株式会社 与多分子的抗原重复结合的抗原结合分子
CA2980992C (en) 2015-04-14 2024-01-23 Akihisa Kaneko Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient
EP3749353A1 (en) 2018-02-09 2020-12-16 Nestlé Skin Health SA Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation
US11236157B2 (en) 2019-01-28 2022-02-01 Galderma Holding SA Treatment of skin lesions and pruritus in prurigo nodularis patients
BR112022006590A2 (pt) 2019-11-20 2022-06-28 Chugai Pharmaceutical Co Ltd Preparação contendo anticorpos
CN116096411A (zh) 2020-09-01 2023-05-09 中外制药株式会社 含有作为活性成分的il-31拮抗剂的用于预防和/或治疗透析瘙痒的药物组合物
TW202304510A (zh) 2021-04-07 2023-02-01 瑞士商葛德瑪控股公司 結節性癢疹之治療
WO2023031770A1 (en) 2021-08-30 2023-03-09 Galderma Holding SA Treatments for atopic dermatitis
US20240141050A1 (en) 2022-09-02 2024-05-02 Galderma Holding S.A. Treatments for prurigo nodularis

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239102A3 (en) 1986-03-28 1989-07-12 Tsuji, Kimiyoshi Process for the formation of human-human hybridoma
JP2898064B2 (ja) * 1989-08-03 1999-05-31 忠三 岸本 ヒトｇｐ１３０蛋白質
GB9016440D0 (en) 1990-07-26 1990-09-12 Elopak Systems A laminate
WO1992003918A1 (en) 1990-08-29 1992-03-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
WO1993002227A1 (en) 1991-07-15 1993-02-04 Eco-Tec Limited Process and apparatus for treating fluoride containing acid solutions
NZ255101A (en) 1992-07-24 1997-08-22 Cell Genesys Inc A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
EP0754225A4 (en) 1993-04-26 2001-01-31 Genpharm Int HETEROLOGIC ANTIBODY-PRODUCING TRANSGENIC NON-HUMAN ANIMALS
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
EP1978033A3 (en) 1995-04-27 2008-12-24 Amgen Fremont Inc. Human antibodies derived from immunized xenomice
CA2219486A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
AUPN481295A0 (en) 1995-08-16 1995-09-07 Medvet Science Pty. Ltd. Agonists of haemopoietic growth factors
AUPN564195A0 (en) * 1995-09-26 1995-10-19 Walter And Eliza Hall Institute Of Medical Research, The A novel haemopoietin receptor and genetic sequences encoding same
AU718899C (en) * 1995-10-23 2004-01-29 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
US6642360B2 (en) * 1997-12-03 2003-11-04 Genentech, Inc. Secreted polypeptides that stimulate release of proteoglycans from cartilage
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
AU759689B2 (en) 1998-06-24 2003-04-17 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor proteins
US20030082734A1 (en) * 1999-06-01 2003-05-01 Dowling Lynette M. Mammalian receptor proteins; related reagents and methods
WO2000073451A1 (en) 1999-06-01 2000-12-07 Schering Corporation Mammalian receptor proteins; related reagents and methods
EP1188830B1 (en) 1999-06-02 2010-01-20 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein ,nr10
AU7445900A (en) 1999-09-27 2001-04-30 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, nr12
AU6135101A (en) * 2000-05-10 2001-11-20 Schering Corp Mammalian receptor proteins; related reagents and methods
PT1325115T (pt) 2000-06-26 2016-09-28 Zymogenetics Inc Recetor de citocina zcytor17
CA2425169A1 (en) 2000-10-06 2002-04-11 Immunex Corporation Hematopoietin receptors hpr1 and hpr2
WO2002077230A1 (fr) 2001-03-26 2002-10-03 Chugai Seiyaku Kabushiki Kaisha Variants d'epissage nr10
PT1576112E (pt) * 2002-01-18 2012-05-25 Zymogenetics Inc Multímeros de receptor de citocina zcytor17
CN100575482C (zh) 2002-01-18 2009-12-30 津莫吉尼蒂克斯公司 新的细胞因子zcytor17配体
ATE431406T1 (de) 2002-02-25 2009-05-15 Genentech Inc Neuer typ-1-cytokinrezeptor glm-r
US7579000B2 (en) * 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
MXPA04010795A (es) 2002-05-01 2005-03-07 Schering Ag Nuevos anticuerpos dirigidos al factor tisular como anticoagulantes.
EP1671642A1 (en) 2004-12-15 2006-06-21 Universite D'angers Compositions comprising (ant)agonists of oncostatin M (OSM), IL-31 and IFN-gamma for modulating keratinocyte migration and functions via a receptor containing OSMRbeta as a subunit, and applications thereof.
ES2579758T3 (es) 2005-01-28 2016-08-16 Zymogenetics, Inc. Preparaciones homogéneas de IL-31
US20060182743A1 (en) * 2005-02-14 2006-08-17 Janine Bilsborough Methods of treating skin disorders using an IL-31RA antagonist
WO2006088955A2 (en) 2005-02-14 2006-08-24 Zymogenetics, Inc. Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
CN101198624B (zh) 2005-05-06 2012-10-10 津莫吉尼蒂克斯公司 Il-31单克隆抗体及使用方法
AU2007249713A1 (en) 2006-01-10 2007-11-22 Zymogenetics, Inc. Methods of treating pain and inflammation in neuronal tissue using IL-31Ra and OSMRb antagonists
DK2047863T3 (da) * 2006-06-08 2013-09-16 Chugai Pharmaceutical Co Ltd Middel til forebyggelse eller behandling af inflammatoriske sygdomme

Also Published As

Publication number Publication date
EP1188830A1 (en) 2002-03-20
EP1188830A4 (en) 2005-02-09
JP2014168462A (ja) 2014-09-18
US20100240145A1 (en) 2010-09-23
JP2009137978A (ja) 2009-06-25
PT1188830E (pt) 2010-04-09
EP2135953B1 (en) 2014-04-23
CY1115582T1 (el) 2017-01-04
JP2016000042A (ja) 2016-01-07
AU4952400A (en) 2000-12-28
JP2012147784A (ja) 2012-08-09
WO2000075314A1 (fr) 2000-12-14
US8362223B2 (en) 2013-01-29
US20180002396A1 (en) 2018-01-04
US8017731B2 (en) 2011-09-13
JP2007111051A (ja) 2007-05-10
ATE455852T1 (de) 2010-02-15
US20100240096A1 (en) 2010-09-23
DE60043728D1 (de) 2010-03-11
US20100016552A1 (en) 2010-01-21
JP2020036596A (ja) 2020-03-12
EP2325316B1 (en) 2016-09-07
EP1188830B1 (en) 2010-01-20
US20030125520A1 (en) 2003-07-03
EP2325316B8 (en) 2017-04-19
EP2325316A1 (en) 2011-05-25
US7482440B2 (en) 2009-01-27
JP2018033461A (ja) 2018-03-08
EP2135953A1 (en) 2009-12-23
JP5634674B2 (ja) 2014-12-03
ES2339843T3 (es) 2010-05-26
US8017738B2 (en) 2011-09-13
US20130115620A1 (en) 2013-05-09

Similar Documents

Publication Publication Date Title
DK1188830T3 (da) Nyt hæmopoietinreceptorprotein NR10
Sporn et al. Autocrine growth factors and cancer
NO995044D0 (no) Osteoprotegerinbindende proteiner og reseptorer
EA200901129A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
DK203489A (da) Anti-t-celle receptor determinanter til diagnosticering og behandling af autoimmune sygdomme
DK1218751T3 (da) Cöliakidiagnose under anvendelse af et gliadinepitop
DK0861261T3 (da) Nukleotid- og proteinsekvenser af hvirveldyrs-Delta-gener og fremgangsmåder baseret derpå
FR2628109A1 (fr) Amphireguline, glycoproteine bifonctionnelle regulatrice de la croissance et son procede de preparation
KR950700995A (ko) 조절 신호인 지방체(oil-body) 단백질 시스-요소(cis-element)(OIL-BODY PROTEIN CIS-ELEMENTS AS REGULATORY SIGNALS)
DE60035517D1 (de) Gl50 moleküle, sowie verwendungen derselben
BR9710665A (pt) Compostos que promovem o desenvolvimento do tecido
GB9722320D0 (en) Human cell cycle checkpoint proteins
Inui et al. Dipeptide transporters
DK0877803T3 (da) OB-proteinreceptor og relaterede sammensætninger og fremgangsmåder
DE69328060T2 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
US7589063B2 (en) Molecules which promote hematopoiesis
DE3751646D1 (de) Rekombinantes Produkt
Westermark et al. Platelet-derived growth factor as a mediator of normal and neoplastic cell proliferation
ATE260339T1 (de) Antikörper gegen menschliches restrictin
WO2023220587A2 (en) Compositions and methods for stimulation of hair growth
NZ547877A (en) Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
FI20000394A0 (fi) GFRa4:n sukuisia tai siitä johdettuja aineita sekä niiden käyttö
WATANABE et al. Molecular Cloning of Novel PHAPII Isoform cDNAs
Droney The evolution of a bmp5 enhancer in primates
Westermark et al. Platelet derived Growth Factor and its Role in Mitogenesis and Transformation B. Westermark*, C.-H. Heldin+* Dept. of Pathology University Hospital S-751 85 Uppsala